Tb4 activates the JNK signaling pathway to increase the expression of pro-inflammatory cytokines in cancer cells (38), and induces the upregulation of ERK phosphorylation to increase the resistance of cancer cells to paclitaxel (39). The gene discussed is MAPK8; the disease is cancer.